Is COVID-19 less severe in CML patients than in those with other haematological cancers?

Br J Haematol. 2022 Feb;196(3):471-472. doi: 10.1111/bjh.17927. Epub 2021 Oct 27.

Author

Simone Claudiani^{1

2}

Affiliations

¹ Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
² Centre for Haematology, Department of Immunology and Inflammation, Hammersmith Campus, Imperial College London, London, UK.

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Hematologic Neoplasms*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
SARS-CoV-2